login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 

Study says that there is no evidence to support concerns that neurodegenerative disease-associated proteins transmit Alzheimer’s or Parkinson’s disease


Tuesday, 12 Feb 2013 11:46
Pathological deposits of Alzheimer's disease and Parkinson's disease-associated proteins
Pathological deposits of Alzheimer's disease and Parkinson's disease-associated proteins

On 4 February 2013, in a study published online in JAMA Neurology, by David Irwin, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA, and colleagues, reported a first group of recipients of cadaver-derived human growth hormone (c-hGH) who do not appear to be at increased risk for Alzheimer and Parkinson disease despite their likely exposure to neurodegenerative disease-associated proteins and elevated risk of infectious prion protein-related disease.


Irwin et al looked for evidence for human-to-human transmission of Alzheimer disease, Parkinson disease, and related neurodegenerative disease-associated proteins in c-hGH recipients. (Image: A=AB, the main component of Alzheimer’s disease-associated plaques, B=Tau, the main component of Alzheimer’s disease-associated tangles, C=Alpha-synuclein, the main component of Lewy bodies in Parkinson’s disease).

The study included 34 routine autopsy patients and a group of c-hGH recipients in the National Hormone and Pituitary Program (NHPP). No cases of Alzheimer’s disease or Parkinson’s disease were identified, according to the study results.

“We found no evidence to support concerns that neurodegenerative disease-associated proteins underlying Alzheimer’s disease and Parkinson’s disease transmit disease in humans despite evidence of their cell-to-cell transmission in model systems of these disorders. Further monitoring is required to confirm these conclusions,” the authors added.




Add New Comment

Related Items


Most popular


Groundbreaking studies find that neurointerventional surgery reduces stroke mortality
Wednesday, 11 Feb 2015
Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live ... Groundbreaking studies find that neurointerventional surgery reduces stroke mortality

FDA approves Pipeline Flex embolisation device
Thursday, 05 Feb 2015
Designed to divert blood flow away from an aneurysm, the Pipeline Flex embolisation device (Medtronic) features a braided cylindrical mesh tube that is implanted across the base or neck of the ... FDA approves Pipeline Flex embolisation device

Next generation Medina coil system shows improvements in early human experience
Thursday, 26 Feb 2015
In early use of the Medina coil system, researchers have found the device to be a next generation coil that combines the familiar procedural safety and technique associated with conventional coils, ... Next generation Medina coil system shows improvements in early human experience

Features


Flow diverter technology for intracranial aneurysms
Tuesday, 31 Mar 2015
Gabor Toth writes for NeuroNews about the flow diverters that are currently available and the ongoing clinical trials that could have the potential to extend the indications of flow diverter therapy ... Flow diverter technology for intracranial aneurysms

Total small-vessel disease score: a new and pragmatic way to assess the full impact of small-vessel disease on the brain
Thursday, 26 Feb 2015
The score provides a more complete overall view of the impact of small-vessel disease on the brain than do the individual MRI features separately. It is a simple and pragmatic visual quantification ... Total small-vessel disease score: a new and pragmatic way to assess the full impact of small-vessel disease on the brain

Profiles


Joseph Broderick
Wednesday, 07 Jan 2015
Joseph Broderick speaks to NeuroNews about the future of neurology and his research, in particular, ... Joseph Broderick

Vladimír Beneš Jr
Tuesday, 30 Sep 2014
Vladimír Beneš Jr is professor and chair at the First Medical School, Charles University, P... Vladimír Beneš Jr

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions